Impact of antimicrobials use in chickens on emergence of drug-resistant campylobacter organisms in humans

International Arabic Journal of Antimicrobial Agents

Volumn 2, Issue 4, 2012, Pages

  Barbour, Elie K ^a,b   Ahmadieh, Diana ^a   Harakeh, Steve ^b   Kumosani, Taha ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Antimicrobials; Campylobacter; Chicken; Drug resistance; Humans

Indexed keywords

EID: 84886875304     PISSN: None     EISSN: 21749094     Source Type: Journal    
DOI: 10.3823/719     Document Type: Article

References (38)

1. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, Pablos-Mendez A, Klugman KP. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005; 5(8): 481-93.
2. Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS). Emergence of Ciprofoxacin-resistant Campylobacter in retail chicken in British Columbia and Saskatchewan. Surveillance Bulletin, Public Health Agency of Canola 2011, http://www.phac-aspc.gc.ca/cipars-picra/bulletin-eng.php. pp.1-4.
3. European Centre for Disease Prevention and Control (ECDC). The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in the European Union in 2009. EFSA Journal 2011; 9: 1-321.
4. National Antimicrobial Resistance Monitoring System. NARMS 2009 Animal Arm Annual Report. United States Department of Agriculture, Agriculture Research service 2009, http://ars.usda.gov/main/docs.htm?docid=22065.
5. Van Looveren M, Daube G, De Zutter L, Dumont JM, Lammens C, Wijdooghe M, Vandamme P, Jouret M, Cornelis M, Goossens H. Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J Antimicrobial Chemotherapy 2001; 48: 235-240.
6. Ursinitsch B, Pless P, Kofer J. Prevalence and Resistance of Campylobacter spp in Styrian Poultry meat. Food safety assurance and veterinary public health. ed. Smulders FJ, Collins JD, Vol. 2, Safety assurance during food processing. 2004. pp. 380-382.
7. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, Johnson BP, Moore KA, Osterholm MT. Quinolone-resistant Campylobacter jejuni infections in Minnesota 1992-1998. New Engl J Med 1999; 340:1525-1532.
8. Savasan S, Ciftçi A, Diker KS. Emergence of quinolone resistance among chicken isolates of Campylobacter in Turkey. Turk J Vet Anim Sci 2004; 28: 391-397.
9. Aquino MH, Filgueiras AL, Ferreira MC, Oliveira SS, Bastos MC, Tibana A. Antimicrobial resistance and plasmid profles of Campylobacter jejuni and Campylobacter coli from humans and animal sources. Lett Appl Microbiol 2002; 34: 149-153.
10. Tauxe RJ. Epidemiology of Campylobacter jejuni infections in the United States and other industrial nations. In Campylobacter jejuni: current status and future trends. (Nachamkin I, Blose MJ, Tompkins LS, Eds.). American Society of Microbiology, DC. 1992. pp. 9-19.
11. De Mol P. Human campylobacteriosis: clinical and epidemiological aspects. Dairy, Food and Environmental Sanitation 1994; 14: 314-316.
12. Randall LP, Ridley AM, Cooles SW, Sharma M, Sayers AR, Pumbwe L, Newell DG, Piddock LJ, Woodward MJ. Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals. J Antimicrob Chemother 2003; 52: 507-510.
13. Mifin JK, Templeton JM, Blackall PJ. Antibiotic resistance in Campylobacter jejuni and Campylobacter coli isolated from poultry in the South-East Queensland region. J Antimicrob Chemother 2007; 59: 775-778.
14. Gallay A, Prouzet-Mouleon V, Kempf I, Lehours P, Labachi L, Camon C, Denis M, de Valk H, Desendos JC, Megraud F. Campylobacter antimicrobial drug resistance among humans, broiler chickens, and pigs, France. Research (CDC) 2007; 13: 1-12.
15. Lutgen EM, McEvoy JM, Sherwood JS, Logue CM. Antimicrobial resistance profling and molecular typing of Campylobacter spp. from processed turkey. BMC Microbiology 2009; 9: 203-209.
16. Guevremont E, Nadeau E, Sirois M, Quessy S. Antimicrobial susceptibilities of thermophilic Campylobacter from humans, swine and chicken broiler. Can J Vet Res 2006; 70: 80-86.
17. De Moura Oliveira KA, Menonca RCS, De Oliveira GV, Sodré AF. Antibiotic resistance of Campylobacter, isolated from automated broiler farms. J Food Safety 2006; 26: 82-91.
18. Norstrom M, Hofshagen M, Stavnes T, Schau J, Lassen J, Kruse H. Antimicrobial resistance in Campylobacter jejuni from humans and broilers in Norway. Epidemiol Infect 2006; 134: 127-130.
19. Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 2006; 58: 243-255.
20. Nelson M, Chiller TM, Powers JH, Angulo FJ. Fluroquinolone-resistant Campylobacter species and the withdrawal of furoquinolone from use in poultry: a public health success story. Clin Infect Dis 2007; 44: 977-980.
21. Lin J, Yan M, Sahin O, Pereira S, Chang YJ, Zhang Q. Effect of Macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrob Agents Chemother 2007, 51: 1678-1686.
22. O'Brien. Ciprofoxacin resistance in Campylobacter jejuni: Case analysis as a tool for elucidating risks at home and abroad. J Antimicrob Chemother 2002; 50 (4): 561-568.
23. Holmes B, Brogden RN, Richards DM. Norfoxacin: a review of antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1985; 30: 482-513.
24. Ericsson CD, Johnson PC, Dupont HL, Morgan DR, Bitsura JAM, de la Cabada FJ. Ciprofoxacin or trimethoprim-sulphamethoxazole as initial therapy for travelers diarrhea. Ann Intern Med 1978; 106: 216-220.
25. Goodman LJ, Trenholme GM, Kaplan RL, Segreti J, Hines D, Petrak R, Nelson JA, Mayer KW, Landau W, Parkhurst GW, Levin S. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med 1990; 150: 541-546.
26. Taylor DN, Sanchez JL, Candler W, Thornton S, McQueen C, Escheverria P. Treatment of travelers diahrrea: ciprofoxacin plus loperamide compared with ciprofoxacin alone. Ann Intern Med 1991; 114: 731-734.
27. Petrucelli BP, Murphy GS, Sanchez JL, Walz S, DeFraites R, Gelnett J, Haberberger RL, Echeverria P, Taylor DN. Treatment of travelers diarrhea with ciprofoxacin and loperamide. J Inf Dis 1992; 165: 557-560.
28. Jacobs-Reitsma WF, Kan CA, Bolder NM. The induction of quinolone resistance in Campylobacter in broilers by quinolone treatment. Lett Appl Microbiol 1994; 19: 228-231.
29. Barbour EK, Hamadeh S, Talhouk R, Sakr W, Darwish R. Evaluation of an enrofoxacin-treatment program against Mycoplasma gallisepticum infection in broilers. Prev Vet Med 1998; 35 (2): 91-99.
30. Endtz HP, Ruijs GS, van Klingeren B, Jansen WH, vander Reyden T, Montou RP. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fuoroquinolones in veterinary medicine. J Antimicrob Chemother 1991; 27: 199-208.
31. Piddock LJV. Quinolone resistance and Campylobacter spp. J Antimicrob Chemother 1995; 36: 891-898.
32. Humphrey TJ, Jorgensen F, Frost JA, Wadda H, Domingue G, Elviss NC, Griggs DJ, Piddock LJV. Prevalence and subtypes of ciprofoxacin resistant campylobacter spp. in commercial focks before, during, and after treatment with fuoroquinolones. Antimicrob Agents Chemother 2005; 49: 690-698.
33. Griggs DJ, Johnson MM, Frost JA, Humphrey T, Jørgensen F, Piddock LJ. Incidence and mechanism of ciprofoxacin resistance in Campylobacter spp. isolated from commercial poultry focks in the United Kingdom before, during, and after fuoroquinolone treatment. Antimicrob Agents Chemother 2005; 49 (2): 699-707.
34. Piddock LJ, Ricci V, Pumbwe L, Everett MJ, Griggs DJ. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J Antimicrob Chemother 2003; 51 (1): 19-26.
35. Luo N, Sahin O, Lin J, Michel LO., Zhang Q. In Vivo selection of Campylobacter isolates with high levels of fuoroquinolone resistance associated with gyrA mutations and the function of the CmeABC effux pump. Antimicrob Agents Chemother. 2003; 47 (1): 390-394.
36. Corcoran D, Quinn T, Cotter L, Fanning S. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. Int J Antimicrob Agents 2006; 27 (1):40-5.
37. Payot S, Avrain L, Magras C, Praud K, Cloeckaert A, Chaslus-Dancla E. Relative contribution of target gene mutation and effux to fuoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. Int J Antimicrob 2004; 23: 468-472.
38. Ge B, McDermott PF, White DG, Meng J. Role of effux pumps and topoisomerase mutations in fuoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2005; 49: 3347-3354.